drugset / Trial / NCT02900352
Zonisamide Treatment of Alcohol Use Disorder: an Evaluation of Efficacy and Mechanism of Action
Phase 3
Completed
156 enrolled
Virginia Commonwealth University
National Institute on Alcohol Abuse and Alcoholism (NIAAA) · collabUniversity of Connecticut · collabVA Connecticut Healthcare System · collabYale University · collab
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This is a randomized, placebo-controlled, double-blind, 16 week trial of the medication zonisamide for the treatment of heavy drinking alcoholic civilians.
Timeline
- Start
- 2016-10
- Primary completion
- 2021-04-22
- Completion
- 2021-04-22
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Zonisamide | Other / unclassified | 500 mg | Oral |